Table 4.
Outcome or subgroup | Studies | Subjects/incisions | Effect estimate OR (95% CI) | p | I 2 |
---|---|---|---|---|---|
Overall | 6 | 733 | 3.06 (2.05, 4.58) | <0.00001 | 0% |
High risk | 4 | 538 | 3.22 (1.79, 5.78) | <0.0001 | 32% |
Normal risk | 2 | 195 | 2.62 (1.20, 5.72) | 0.02 | 0% |
Szilagyi I | 4 | 568 | 3.09 (1.68, 5.67) | 0.0003 | 0% |
Szilagyi II | 4 | 568 | 1.92 (0.34, 10.82) | 0.46 | 67% |
Szilagyi III | 4a | 568 | 3.01 (0.93, 9.77) | 0.07 | 0% |
I2 = measure of heterogeneity. Bold p values indicate statistically significant p value.
aOne study in the Szilagyi III analysis reported no events in either the ciNPT or control group.